Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in Eisenmenger syndrome (China)
CTR20132091Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macitentan in Eisenmenger syndrome, sponsored by Actelion Pharmaceuticals Ltd. Started Jul 2015; status: completed.
02
Drugs
macitentan
03
Conditions
Eisenmenger syndrome
Beyond the preview
Go deeper on CTR20132091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132091.